Multifaceted empathy of healthy volunteers after single doses of MDMA: A pooled sample of placebo-controlled studies

Kim Pc Kuypers, Patrick C Dolder, Johannes G Ramaekers, Matthias E Liechti

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Previous placebo-controlled experimental studies have shown that a single dose of MDMA can increase emotional empathy in the multifaceted empathy test (MET) without affecting cognitive empathy. Although sufficiently powered to detect main effects of MDMA, these studies were generally underpowered to also validly assess contributions of additional parameters, such as sex, drug use history, trait empathy and MDMA or oxytocin plasma concentrations. The present study examined the robustness of the MDMA effect on empathy and investigated the moderating role of these additional parameters. Participants ( n = 118) from six placebo-controlled within-subject studies and two laboratories were included in the present pooled analysis. Empathy (MET), MDMA and oxytocin plasma concentrations were assessed after oral administration of MDMA (single dose, 75 or 125 mg). Trait empathy was assessed using the interpersonal reactivity index. We confirmed that MDMA increased emotional empathy at both doses without affecting cognitive empathy. This MDMA-related increase in empathy was most pronounced during presentation of positive emotions as compared with negative emotions. MDMA-induced empathy enhancement was positively related to MDMA blood concentrations measured before the test, but independent of sex, drug use history and trait empathy. Oxytocin concentrations increased after MDMA administration but were not associated with behavioral effects. The MDMA effects on emotional empathy were stable across laboratories and doses. Sex did not play a moderating role in this effect, and oxytocin levels, trait empathy and drug use history were also unrelated. Acute drug exposure was of significant relevance in the MDMA-induced emotional empathy elevation.

Original languageEnglish
Pages (from-to)589–598
Number of pages10
JournalJournal of Psychopharmacology
Volume31
Issue number5
Early online date1 Mar 2017
DOIs
Publication statusPublished - May 2017

Keywords

  • Journal Article
  • emotional empathy
  • EMOTIONAL EMPATHY
  • sex
  • pooled data analysis
  • HUMANS
  • MDMA
  • POSITIVE EMOTIONS
  • INDIVIDUAL-DIFFERENCES
  • ECSTASY
  • MOOD
  • 3,4-METHYLENEDIOXYMETHAMPHETAMINE
  • OXYTOCIN
  • METHYLPHENIDATE
  • PROSOCIAL FEELINGS
  • cognitive empathy

Cite this

@article{d64a17d6707b46de90eea66f53ee6078,
title = "Multifaceted empathy of healthy volunteers after single doses of MDMA: A pooled sample of placebo-controlled studies",
abstract = "Previous placebo-controlled experimental studies have shown that a single dose of MDMA can increase emotional empathy in the multifaceted empathy test (MET) without affecting cognitive empathy. Although sufficiently powered to detect main effects of MDMA, these studies were generally underpowered to also validly assess contributions of additional parameters, such as sex, drug use history, trait empathy and MDMA or oxytocin plasma concentrations. The present study examined the robustness of the MDMA effect on empathy and investigated the moderating role of these additional parameters. Participants ( n = 118) from six placebo-controlled within-subject studies and two laboratories were included in the present pooled analysis. Empathy (MET), MDMA and oxytocin plasma concentrations were assessed after oral administration of MDMA (single dose, 75 or 125 mg). Trait empathy was assessed using the interpersonal reactivity index. We confirmed that MDMA increased emotional empathy at both doses without affecting cognitive empathy. This MDMA-related increase in empathy was most pronounced during presentation of positive emotions as compared with negative emotions. MDMA-induced empathy enhancement was positively related to MDMA blood concentrations measured before the test, but independent of sex, drug use history and trait empathy. Oxytocin concentrations increased after MDMA administration but were not associated with behavioral effects. The MDMA effects on emotional empathy were stable across laboratories and doses. Sex did not play a moderating role in this effect, and oxytocin levels, trait empathy and drug use history were also unrelated. Acute drug exposure was of significant relevance in the MDMA-induced emotional empathy elevation.",
keywords = "Journal Article, emotional empathy, EMOTIONAL EMPATHY, sex, pooled data analysis, HUMANS, MDMA, POSITIVE EMOTIONS, INDIVIDUAL-DIFFERENCES, ECSTASY, MOOD, 3,4-METHYLENEDIOXYMETHAMPHETAMINE, OXYTOCIN, METHYLPHENIDATE, PROSOCIAL FEELINGS, cognitive empathy",
author = "Kuypers, {Kim Pc} and Dolder, {Patrick C} and Ramaekers, {Johannes G} and Liechti, {Matthias E}",
year = "2017",
month = "5",
doi = "10.1177/0269881117699617",
language = "English",
volume = "31",
pages = "589–598",
journal = "Journal of Psychopharmacology",
issn = "0269-8811",
publisher = "SAGE Publications Ltd",
number = "5",

}

Multifaceted empathy of healthy volunteers after single doses of MDMA : A pooled sample of placebo-controlled studies. / Kuypers, Kim Pc; Dolder, Patrick C; Ramaekers, Johannes G; Liechti, Matthias E.

In: Journal of Psychopharmacology, Vol. 31, No. 5, 05.2017, p. 589–598.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Multifaceted empathy of healthy volunteers after single doses of MDMA

T2 - A pooled sample of placebo-controlled studies

AU - Kuypers, Kim Pc

AU - Dolder, Patrick C

AU - Ramaekers, Johannes G

AU - Liechti, Matthias E

PY - 2017/5

Y1 - 2017/5

N2 - Previous placebo-controlled experimental studies have shown that a single dose of MDMA can increase emotional empathy in the multifaceted empathy test (MET) without affecting cognitive empathy. Although sufficiently powered to detect main effects of MDMA, these studies were generally underpowered to also validly assess contributions of additional parameters, such as sex, drug use history, trait empathy and MDMA or oxytocin plasma concentrations. The present study examined the robustness of the MDMA effect on empathy and investigated the moderating role of these additional parameters. Participants ( n = 118) from six placebo-controlled within-subject studies and two laboratories were included in the present pooled analysis. Empathy (MET), MDMA and oxytocin plasma concentrations were assessed after oral administration of MDMA (single dose, 75 or 125 mg). Trait empathy was assessed using the interpersonal reactivity index. We confirmed that MDMA increased emotional empathy at both doses without affecting cognitive empathy. This MDMA-related increase in empathy was most pronounced during presentation of positive emotions as compared with negative emotions. MDMA-induced empathy enhancement was positively related to MDMA blood concentrations measured before the test, but independent of sex, drug use history and trait empathy. Oxytocin concentrations increased after MDMA administration but were not associated with behavioral effects. The MDMA effects on emotional empathy were stable across laboratories and doses. Sex did not play a moderating role in this effect, and oxytocin levels, trait empathy and drug use history were also unrelated. Acute drug exposure was of significant relevance in the MDMA-induced emotional empathy elevation.

AB - Previous placebo-controlled experimental studies have shown that a single dose of MDMA can increase emotional empathy in the multifaceted empathy test (MET) without affecting cognitive empathy. Although sufficiently powered to detect main effects of MDMA, these studies were generally underpowered to also validly assess contributions of additional parameters, such as sex, drug use history, trait empathy and MDMA or oxytocin plasma concentrations. The present study examined the robustness of the MDMA effect on empathy and investigated the moderating role of these additional parameters. Participants ( n = 118) from six placebo-controlled within-subject studies and two laboratories were included in the present pooled analysis. Empathy (MET), MDMA and oxytocin plasma concentrations were assessed after oral administration of MDMA (single dose, 75 or 125 mg). Trait empathy was assessed using the interpersonal reactivity index. We confirmed that MDMA increased emotional empathy at both doses without affecting cognitive empathy. This MDMA-related increase in empathy was most pronounced during presentation of positive emotions as compared with negative emotions. MDMA-induced empathy enhancement was positively related to MDMA blood concentrations measured before the test, but independent of sex, drug use history and trait empathy. Oxytocin concentrations increased after MDMA administration but were not associated with behavioral effects. The MDMA effects on emotional empathy were stable across laboratories and doses. Sex did not play a moderating role in this effect, and oxytocin levels, trait empathy and drug use history were also unrelated. Acute drug exposure was of significant relevance in the MDMA-induced emotional empathy elevation.

KW - Journal Article

KW - emotional empathy

KW - EMOTIONAL EMPATHY

KW - sex

KW - pooled data analysis

KW - HUMANS

KW - MDMA

KW - POSITIVE EMOTIONS

KW - INDIVIDUAL-DIFFERENCES

KW - ECSTASY

KW - MOOD

KW - 3,4-METHYLENEDIOXYMETHAMPHETAMINE

KW - OXYTOCIN

KW - METHYLPHENIDATE

KW - PROSOCIAL FEELINGS

KW - cognitive empathy

U2 - 10.1177/0269881117699617

DO - 10.1177/0269881117699617

M3 - Article

C2 - 28372480

VL - 31

SP - 589

EP - 598

JO - Journal of Psychopharmacology

JF - Journal of Psychopharmacology

SN - 0269-8811

IS - 5

ER -